HRP921482B1 - Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof - Google Patents

Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof

Info

Publication number
HRP921482B1
HRP921482B1 HRP-1842/91A HRP921482A HRP921482B1 HR P921482 B1 HRP921482 B1 HR P921482B1 HR P921482 A HRP921482 A HR P921482A HR P921482 B1 HRP921482 B1 HR P921482B1
Authority
HR
Croatia
Prior art keywords
sodium
enalapril
stable formulation
chem
formula
Prior art date
Application number
HRP-1842/91A
Other languages
English (en)
Inventor
Merslavič Marjo
Ražen Jožica
Rotar Aleue
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25555813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP921482(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka filed Critical Krka
Priority to HRP-1842/91A priority Critical patent/HRP921482B1/xx
Publication of HRP921482A2 publication Critical patent/HRP921482A2/xx
Publication of HRP921482B1 publication Critical patent/HRP921482B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HRP-1842/91A 1991-11-25 1992-12-30 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof HRP921482B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-1842/91A HRP921482B1 (en) 1991-11-25 1992-12-30 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila
HRP-1842/91A HRP921482B1 (en) 1991-11-25 1992-12-30 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof

Publications (2)

Publication Number Publication Date
HRP921482A2 HRP921482A2 (en) 1996-12-31
HRP921482B1 true HRP921482B1 (en) 2000-04-30

Family

ID=25555813

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1842/91A HRP921482B1 (en) 1991-11-25 1992-12-30 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof

Country Status (11)

Country Link
US (1) US5350582A (xx)
EP (1) EP0545194B1 (xx)
AT (1) ATE150650T1 (xx)
CA (1) CA2083683C (xx)
DE (1) DE69218557T2 (xx)
DK (1) DK0545194T3 (xx)
ES (1) ES2101004T3 (xx)
GR (1) GR3023655T3 (xx)
HR (1) HRP921482B1 (xx)
SI (1) SI9111842A (xx)
YU (1) YU48602B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128199C (en) * 1994-07-15 1997-02-04 Bernard Charles Sherman Stable solid pharmaceutical compositions containing enalapril maleate
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
CA2302832A1 (en) * 1998-07-21 2000-02-03 Kaneka Corporation Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline
NZ333206A (en) 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
RS53324B (en) 2005-11-17 2014-10-31 Silverstone Pharma Est. STABLE FORMULATION OF AMORPHIC SALES OF PERINDOPRIL, PROCEDURE FOR THEIR PREPARATION, IN PARTICULAR INDUSTRIAL PREPARATION, AND THEIR USE IN HYPERTENSION THERAPY
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
CA2922536C (en) 2013-08-28 2022-05-03 Psychemedics Corporation Integrity testing of hair samples
RS58120B1 (sr) 2014-07-31 2019-02-28 Pharmathen Sa Kompozicija orodisperzibilnog filma koja sadrži enalapril za lečenje hipertenzije kod pedijatrijske populacije

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
EP0391462A1 (en) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Synergistic compositions containing ketanserin

Also Published As

Publication number Publication date
EP0545194A1 (en) 1993-06-09
GR3023655T3 (en) 1997-09-30
DE69218557D1 (de) 1997-04-30
CA2083683C (en) 2000-09-05
ATE150650T1 (de) 1997-04-15
CA2083683A1 (en) 1993-05-26
YU184291A (sh) 1994-04-05
DK0545194T3 (da) 1997-07-28
EP0545194B1 (en) 1997-03-26
HRP921482A2 (en) 1996-12-31
US5350582A (en) 1994-09-27
DE69218557T2 (de) 1997-11-13
YU48602B (sh) 1998-12-23
ES2101004T3 (es) 1997-07-01
SI9111842A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
GR3023655T3 (en) Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof
IL70540A (en) Plant bactericidal and fungicidal compositions containing 1-cycloproply-quinolonecarboxylic acid and method for using them
DE3167774D1 (en) 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
CA2047783A1 (en) Stable solution of sodium hypochlorite
HU901193D0 (en) Process for protection against phytopathogenic bacteria using phosphonic acid derivatives
AU575400B2 (en) Piperidine and imidazole and amino salt derivatives as plant growth regulators
FI843354A0 (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
JPS57188515A (en) Stabilized aqueous dopamine preparation
DE3164005D1 (en) Use of alpha-azolylglycoles as plant growth regulators
MX9705836A (es) Sales de zinc del acido citraconamico y compuestos de hule que contienen estas sales.
HUT53528A (en) Process for production of having antiviral effectg, well suluable in water stabil cristallic salts of 2',3' dideozoxiinozin- monohidrat, 2',3'-didezoxi-2'3'-didohydrotimidin monohydrate and 2',3' didezoxi-2'-fluor-inosine-hemihydrate and medical compositions containing these salts
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
ES8504829A1 (es) Un procedimiento para la preparacion de un acido -hidroxietilfosfinico
DE69608260D1 (en) Wässrige spectinomycinborat-auflösung
ES8500266A1 (es) "procedimiento para la preparacion de nuevos acidos benzoilparabanicos"
GR3001965T3 (en) Salts of 6-piperidino-2,4-diaminopyrimidin-3-oxide and of derivatives of thiamorpholin-3-on-5-carboxylic acid, their cosmetical and medicinal use
IL75742A0 (en) Phenylethylaminopropiophenone derivatives,their preparation and pharmaceutical compositions containing them
DE3262339D1 (en) Herbicidal agents
HUT38090A (en) Process for production of derivatives of 2,2,5,2-tetraalkyl-cyclohexan-4-on-1-ol
SE8400451D0 (sv) Bronchodilatory azepino /1,2-a/pyrimidine derivatives and acid addition salts thereof and pharmaceutical compositions containig same
ES8607944A1 (es) Procedimiento para la preparacion de nuevos derivados de 1- fenilimidazolidin-2-ona
GR3007320T3 (xx)
NZ217290A (en) Preparation of bromofluoroacetic acid derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: KRKA, TOVARNA ZDRAVIL, D.D., SI

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20011125

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20021126